Clinical Trials
27 trialsEstablishment of a Prospective Clinical Cohort of Small Cell Lung Cancer Patients Receiving Radiotherapy-Involved Comprehensive Treatment
Shanghai Chest Hospital
Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland
Bristol-Myers Squibb
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer
SWOG Cancer Research Network
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
PrECOG, LLC.
LUDICAS
Fundación GECP
Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Long-Term Safety Outcomes and First-Line Treatment Patterns in Patients With Non-Small Cell Lung Cancer and Programmed Death-1 (Pd-L1) <1%
Bristol-Myers Squibb
Clinical Outcomes of Tislelizumab Combined With Chemotherapy as Induction Therapy in Stage III (cTNM-IIIB/IIIC) NSCLC
West China Hospital
Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer
Zhejiang Cancer Hospital
Molecular Analysis and Treatment Options of Thymic Malignancies
Shanghai Chest Hospital
AI-HOPE Lung Cancer: Building a Predictive Tool for Metastatic Lung Cancer
IRCCS San Raffaele
ROOT
Taproot Health
Molecular Analysis and Treatment Options of SCLC
Shanghai Chest Hospital
Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLC
Capital Medical University
HIBIC-NSCLC
The First People's Hospital of Neijiang
CREATE
Hunan Province Tumor Hospital
Relation Between Tumor-draining Lymph Nodes Metastasis Pattern and Non-small Cell Lung Cancer Neoadjuvant Immunotherapy Effectiveness
Sun Yat-sen University
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
Persephone Biosciences
A Real-world Study of Adebrelimab Combined With Chemotherapy±Chest Radiotherapy in Patients With Extensive Stage Small Cell Lung Cancer
Hebei Medical University Fourth Hospital
Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer
The First Hospital of Jilin University
Minimal Residual Disease Dynamic Monitoring in First-Line Serplulimab Plus Chemotherapy in Treatment of Extensive Small Cell Lung Cancer: An Observational Study
The First Hospital of Jilin University
G-DEFINER
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Radiation Pneumonitis After SBRT for NSCLC
Sykehuset i Vestfold HF
ctDNA as a Biomarker for Treatment in Advanced NSCLC
Fuzhou General Hospital
A Real-world Study of Durvalumab for Lung Cancer in China
Peking Union Medical College Hospital
Clinical Study of Chemotherapy Combined With Chinese Medicine on Survival Affect of Elderly Patients With Lung Cancer
Shanghai University of Traditional Chinese Medicine
Isolated Thoracic Perfusion (ITP-F) for MPM
Medias Klinikum for Surgical Oncology